Similar articles

• Twenty-year evolution of percutaneous coronary intervention and its impact on clinical outcomes: a report from the National Heart, Lung, and Blood Institute-sponsored, multicenter 1985-1986 PTCA and 1997-2006 Dynamic Registries.

  Venkitachalam L, Kip KE, Selzer F, Wilensky RL, Slater J, Mulukutla SR, Marroquin OC, Block PC, Williams DO, Kelsey SF; Investigators of NHLBI-Sponsored 1985-1986 PTCA and 1997-2006 Dynamic Registries. Venkitachalam L, et al. Circ Cardiovasc Interv. 2009 Feb;2(1):6-13. doi: 10.1161/CIRCINTERVENTIONS.108.825323. Epub 2008 Dec 15. Circ Cardiovasc Interv. 2009. PMID: 20031687 Free PMC article.
• Percutaneous revascularization of the "unprotected" left main during acute myocardial infarction: "Dare to struggle! Dare to win!".

  Morrison DA. Morrison DA. Catheter Cardiovasc Interv. 2009 Jan 1;73(1):22-4. doi: 10.1002/ccd.21909. Catheter Cardiovasc Interv. 2009. PMID: 19089931 No abstract available.
• Trifurcation left main coronary artery percutaneous revascularization--pushing catheters and envelopes.

  Moliterno DJ. Moliterno DJ. Catheter Cardiovasc Interv. 2009 Jan 1;73(1):32-3. doi: 10.1002/ccd.21907. Catheter Cardiovasc Interv. 2009. PMID: 19089933 No abstract available.
• Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.

  Doostzadeh J, Clark LN, Bezenek S, Pierson W, Sood PR, Sudhir K. Doostzadeh J, et al. Coron Artery Dis. 2010 Jan;21(1):46-56. doi: 10.1097/MCA.0b013e328333f550. Coron Artery Dis. 2010. PMID: 19952925 Review.
• Stent choice in primary percutaneous coronary intervention: drug-eluting stents or bare metal stents?

  Valgimigli M, Airoldi F, Zimarino M. Valgimigli M, et al. J Cardiovasc Med (Hagerstown). 2009 Oct;10 Suppl 1:S17-26. doi: 10.2459/01.JCM.0000362040.25767.f5. J Cardiovasc Med (Hagerstown). 2009. PMID: 19851216 Review.